Ame Company For Medical Supplies (9527.SR)
SAR 118.0
(0.0%)
SAR 118.0
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | 36.65 Million | 8.47 Million | 20.26 Million | 11.61 Million | 10.99 Million |
| Net Income | 33.51 Million | 26.68 Million | 21.22 Million | 21.07 Million | 14.81 Million |
| Depreciation & Amortization | 1.53 Million | 853.5 Thousand | 458.85 Thousand | 291.86 Thousand | 108.5 Thousand |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - |
| Change in working capital | -5.06 Million | -17.63 Million | -7.87 Million | -14.16 Million | -5.38 Million |
| Other non-cash items | 6.67 Million | -1.42 Million | 6.45 Million | 23.78 Million | 6.29 Million |
| Investing Cash Flow | -1.93 Million | -814.46 Thousand | -259.53 Thousand | -305.01 Thousand | -190.96 Thousand |
| Investments in PPE | -1.93 Million | -814.46 Thousand | -335.03 Thousand | -305.01 Thousand | -190.96 Thousand |
| Acquisitions | - | - | 75.5 Thousand | - | - |
| Investment purchases | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - |
| Financing Cash Flow | -14.63 Million | -12.75 Million | -6.28 Million | -4.54 Million | -11.61 Million |
| Debt repayment | - | - | -4.5 Million | -4.5 Million | - |
| Dividends payments | -13.98 Million | -12.25 Million | -1.6 Million | - | - |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - |
| Other Financing Activities | -647.17 Thousand | -505.1 Thousand | -187.5 Thousand | -8.85 Million | -11.48 Million |
| Accounts receivables | -13.35 Million | -295.65 Thousand | -13.05 Million | -14.08 Million | 3.4 Million |
| Accounts payables | 511.38 Thousand | -246.62 Thousand | 244.57 Thousand | -5.85 Million | 1.54 Million |
| Inventory | 1.27 Million | -21.55 Million | -2.98 Million | 1.15 Million | -9.56 Million |
| Other working capital | 6.49 Million | 4.46 Million | 7.91 Million | 4.61 Million | -766.66 Thousand |
| Cash at beginning of period | 23.32 Million | 28.41 Million | 14.69 Million | 7.93 Million | 8.74 Million |
| Cash at end of period | 43.4 Million | 23.32 Million | 28.41 Million | 14.69 Million | 7.93 Million |
| Capital Expenditure | -1.93 Million | -814.46 Thousand | -335.03 Thousand | -305.01 Thousand | -190.96 Thousand |
| Effect of forex changes on cash | - | - | - | - | - |
| Net cash flow / Change in cash | 20.08 Million | -5.09 Million | 13.71 Million | 6.76 Million | -812.9 Thousand |
| Free Cash Flow | 34.71 Million | 7.65 Million | 19.92 Million | 11.31 Million | 10.8 Million |
| Breakdown | 2024 Q2 | 2023 FY | 2023 Q4 | 2023 Q2 | 2022 Q4 | 2022 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 26.59 Million | 33.51 Million | 11.31 Million | 22.19 Million | 11.3 Million | 26.68 Million |
| Depreciation & Amortization | 946.84 Thousand | 1.53 Million | 824.11 Thousand | 711.14 Thousand | 478.1 Thousand | 853.5 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -44.82 Million | -5.06 Million | 1.59 Million | -6.66 Million | 9.57 Million | -17.63 Million |
| Other non-cash items | 31.33 Million | 6.67 Million | 3.8 Million | 17.5 Million | -8.43 Million | -1.42 Million |
| Investing Cash Flow | -59.68 Thousand | -1.93 Million | -389.76 Thousand | -1.54 Million | -87.91 Thousand | -814.46 Thousand |
| Investments in PPE | -59.68 Thousand | -1.93 Million | -389.76 Thousand | -1.54 Million | -87.91 Thousand | -814.46 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | -14.74 Million | -14.63 Million | -13.16 Thousand | -14.62 Million | -113 Thousand | -12.75 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | -14 Million | -13.98 Million | - | -13.98 Million | - | -12.25 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -749.54 Thousand | - | - | -634 Thousand | - | -505.1 Thousand |
| Accounts receivables | -24.58 Million | -13.35 Million | 3.8 Million | -17.16 Million | 17.79 Million | -295.65 Thousand |
| Accounts payables | 85.57 Thousand | 511.38 Thousand | 511.38 Thousand | 1.00 | -399.53 Thousand | -246.62 Thousand |
| Inventory | -7.21 Million | 1.27 Million | -2.82 Million | 4.1 Million | -12.85 Million | -21.55 Million |
| Other working capital | -13.11 Million | 6.49 Million | 96.88 Thousand | 6.4 Million | 5.03 Million | 4.46 Million |
| Cash at beginning of period | 43.4 Million | 23.32 Million | 26.41 Million | 23.32 Million | 7 Million | 28.41 Million |
| Cash at end of period | 9.03 Million | 43.4 Million | 43.4 Million | 26.41 Million | 23.32 Million | 23.32 Million |
| Capital Expenditure | -59.68 Thousand | -1.93 Million | -389.76 Thousand | -1.54 Million | -87.91 Thousand | -814.46 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -34.36 Million | 20.08 Million | 16.98 Million | 3.09 Million | 16.31 Million | -5.09 Million |
| Free Cash Flow | -19.61 Million | 34.71 Million | 16.99 Million | 17.72 Million | 16.42 Million | 7.65 Million |
PGUCY
9307
TKSHF
GCB
PSPPROJECT
3922